The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Lyell Immunopharma Inc (NASDAQ: LYEL) was $1.24 for the day, down -2.36% from the previous closing price of $1.27. In other words, the price has decreased by -$2.36 from its previous closing price. On the day, 1.26 million shares were traded. LYEL stock price reached its highest trading level at $1.34 during the session, while it also had its lowest trading level at $1.14.
Ratios:
Our analysis of LYEL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 16.19 and its Current Ratio is at 16.19. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on October 30, 2024, Downgraded its rating to Underperform and sets its target price to $1 from $6 previously.
On June 27, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $1.
JP Morgan Downgraded its Overweight to Neutral on August 28, 2023, whereas the target price for the stock was revised from $15 to $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LYEL now has a Market Capitalization of 328438816 and an Enterprise Value of -113454136. For the stock, the TTM Price-to-Sale (P/S) ratio is 6348.80 while its Price-to-Book (P/B) ratio in mrq is 0.56. Its current Enterprise Value per Revenue stands at -2101.003 whereas that against EBITDA is 0.555.
Stock Price History:
Over the past 52 weeks, LYEL has reached a high of $3.26, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 0.29%, while the 200-Day Moving Average is calculated to be -33.86%.
Shares Statistics:
LYEL traded an average of 1.04M shares per day over the past three months and 3176240 shares per day over the past ten days. A total of 253.96M shares are outstanding, with a floating share count of 114.05M. Insiders hold about 55.45% of the company’s shares, while institutions hold 25.12% stake in the company. Shares short for LYEL as of 1728950400 were 10759090 with a Short Ratio of 10.39, compared to 1726185600 on 13222068. Therefore, it implies a Short% of Shares Outstanding of 10759090 and a Short% of Float of 5.96.
